United States Healthcare Equipment & Supplies

Bionano Genomics, Inc. (BNGO)

Track

Track

Bionano Genomics Inc. witnessed two recent insider trading transactions, both involving interim chief executive Albert Luderer. These acquisitions totaled 9,704.8 USD in value during late August and early September 2026. This activity follows a positive earnings report released in mid-August, occurring amidst a period where the stock price experienced significant volatility.
Ticker: BNGO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Bionano Genomics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Luderer Albert Interim Chief Executive Executive Director
Transaction date
Purchase
Price
106.47
Quantity 21,982 +2.5%
Value US$192,916
Luderer Albert Interim Chief Executive Executive Director
Transaction date
Purchase
Price
269.23
Quantity 86,587 +21.2%
Value US$1,745,524
0.5
Mamuszka Hannah Non-Executive Director
Transaction date
Purchase
Price
243.98
Quantity 68,561 +9.8%
Value US$4,886,960
1.2
Holmlin R. Erik President and CEO Executive Director
Transaction date
Purchase
Price
0.64
Quantity 15,000 +1.9%
Value US$9,639
1.4
Stewart Christopher P. Chief Financial Officer Officer
Transaction date
Purchase
Price
0.67
Quantity 50,000 +21.6%
Value US$33,415
3.3
Linney Yvonne Non-Executive Director
Transaction date
Sale
Price
3.62
Quantity 20,000 -100.0%
Value US$72,402
2.4
BARKER DAVID L Non-Executive Director
Transaction date
Purchase
Price
1.60
Quantity 10,000 +256.8%
Value US$16,000
1.2
Holmlin R. Erik President and CEO Executive Director
Transaction date
Purchase
Price
3.98
Quantity 150 +3.1%
Value US$597
1.2
Holmlin R. Erik President and CEO Executive Director
Transaction date
Purchase
Price
3.99
Quantity 2,675 +121.6%
Value US$10,673
1.2
Holmlin R. Erik President and CEO Executive Director
Transaction date
Purchase
Price
3.99
Quantity 2,200 +inf%
Value US$8,767
TWOMEY CHRISTOPHER J Non-Executive Director
Transaction date
Purchase
Price
6.13
Quantity 10,000 +inf%
Value US$61,250
Domain Partners VIII, L.P. Large shareholder
Transaction date
Purchase
Price
6.13
Quantity 15,000 +1.6%
Value US$91,875
Holmlin R. Erik President and CEO Executive Director
Transaction date
Purchase
Price
6.13
Quantity 1,630 +inf%
Value US$9,984
Borodkin Mark Chief Operating Officer Officer
Transaction date
Purchase
Price
6.13
Quantity 815 +inf%
Value US$4,992
BARKER DAVID L Non-Executive Director
Transaction date
Purchase
Price
6.47
Quantity 3,894 +inf%
Value US$25,194
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-09 2026-09-04 B Purchase
Luderer Albert

Interim Chief Executive

Executive Director
21,982 +2.5%
106.47
US$192,916 		21,982 +2.5% 106.47 US$192,916
2026-08-21 2026-08-21 B Purchase
Luderer Albert

Interim Chief Executive

Executive Director
86,587 +21.2%
269.23
US$1,745,524 		86,587 +21.2% 269.23 US$1,745,524
2023-06-14 2023-06-13 B Purchase
0.5
Mamuszka Hannah
Non-Executive Director
68,561 +9.8%
243.98
US$4,886,960 		68,561 +9.8% 243.98 US$4,886,960
2023-05-16 2023-05-16 B Purchase
1.2
Holmlin R. Erik

President and CEO

Executive Director
15,000 +1.9%
0.64
US$9,639 		15,000 +1.9% 0.64 US$9,639
2023-05-16 2023-05-12 B Purchase
1.4
Stewart Christopher P.

Chief Financial Officer

Officer
50,000 +21.6%
0.67
US$33,415 		50,000 +21.6% 0.67 US$33,415
2022-08-17 2022-08-15 S Sale
3.3
Linney Yvonne
Non-Executive Director
20,000 -100.0%
3.62
US$72,402 		20,000 -100.0% 3.62 US$72,402
2022-05-18 2022-05-16 B Purchase
2.4
BARKER DAVID L
Non-Executive Director
10,000 +256.8%
1.60
US$16,000 		10,000 +256.8% 1.60 US$16,000
2021-12-01 2021-11-29 B Purchase
1.2
Holmlin R. Erik

President and CEO

Executive Director
150 +3.1%
3.98
US$597 		150 +3.1% 3.98 US$597
2021-12-01 2021-11-29 B Purchase
1.2
Holmlin R. Erik

President and CEO

Executive Director
2,675 +121.6%
3.99
US$10,673 		2,675 +121.6% 3.99 US$10,673
2021-12-01 2021-11-29 B Purchase
1.2
Holmlin R. Erik

President and CEO

Executive Director
2,200 +inf%
3.99
US$8,767 		2,200 +inf% 3.99 US$8,767
2018-08-27 2018-08-23 B Purchase TWOMEY CHRISTOPHER J Non-Executive Director
10,000 +inf%
6.13
US$61,250 		10,000 +inf% 6.13 US$61,250
2018-08-27 2018-08-23 B Purchase Domain Partners VIII, L.P. Large shareholder
15,000 +1.6%
6.13
US$91,875 		15,000 +1.6% 6.13 US$91,875
2018-08-27 2018-08-23 B Purchase Holmlin R. Erik

President and CEO

Executive Director
1,630 +inf%
6.13
US$9,984 		1,630 +inf% 6.13 US$9,984
2018-08-27 2018-08-23 B Purchase Borodkin Mark

Chief Operating Officer

Officer
815 +inf%
6.13
US$4,992 		815 +inf% 6.13 US$4,992
2018-10-03 2018-08-21 B Purchase BARKER DAVID L Non-Executive Director
3,894 +inf%
6.47
US$25,194 		3,894 +inf% 6.47 US$25,194
Explore more

More insider trading research around Bionano Genomics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America